Revista Peruana de Reumatología: Volumen 2 Nº 2, Año 1996 LIMA-PERÚ

Bibliografía

1. Meunier PJ. Is steroid-induced osteoporosis preventable? N Engl Med 1993; 328: 1781-2.

2. Laan RFJM, van Riel PLCM et al. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br. J Rheumatol 1992; 31: 91-6.

3. Lukert BP, Raisz LG. Glucocorticoid-induce osteoporosis, Rheumatic Disease Clinics of North America 1994; 20, 3: 629-650.

4. Doherty EJ, DeRome ME, MC Carthy MB, Gronowicz GA. The effect of glucocorticoids on osteoblast funtion, J Bone Jt Surg 1995; 77A: 396-404.

5. Hosking DJ. Effects of corticosteroids on bone tumover. Respir Med 1993; 87 SuppI A: 15-21.

6. Hahn TJ. Steroid and Drug-Induced Osteopenia. Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism 1993; 2nd Edition: 250-252.

7. Olbricht T, Benker G. Glucocorticoid induced osteoporosis: pathogenesis, prevention and treatment with special regard to the rheumatic diseases. J Int Med 1993; 234: 237-244.

8. Olgaard K, Storm T et al. Glucocorticoid induced osteoporosis in the lumbar spine, forearm and mandible of nephrotic patients; a double blind study on the high dose, long term effects of prednisones versus deflazacort. Calcif Tiss Int. 1992; 50: 490-7.

9. Gray RS, Doherty SM, Galloway J, et al. A double blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheum 1991; 34: 287-295.

10. Loftus J, Allen R, Hesp R, et al. Randomized double blind trial of Deflazacort versus Prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of Deflazacort. Pediatrics 1991; 88: 428-436.

11. Messina ODD, Barrerira JC, et al. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol 1992; 19: 1520-1526.

12. Gluck OS, Murphy WA, et al. Bone loss in adults receiving alternate day glucocorticoid therapy: A comparison with dayly therapy. Arhritis Rheum 1985; 24: 892.

13. Ruegesegger P, Medici TC, Anlinder M. Corticosteroi-induce bone loss: A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983; 25: 615.

14. Boulet LP, Giguere MC, et al. Effects of long term use of high dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 1994; 94: 796-803.

15. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J med 1995; 332: 868-875.

16. Utiger RD. Differences between inhaled and oral glucocorticoid therapy. N Engl J Med 1993; 329: 1731-1733.

17. Packe GE, Douglas JG et al. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992; 47: 414-417.

18. Garton MJ, Reid DM. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with Rheumatoid Arthritis, effects of low-dose corticosteroids. Arthritis Rheum 1993; 36: 222-228.

19. Laan RF JM, van Riel PL CM et al. Vertebral osteoporosis in Rheumatoid arthritis patients: effect of low dose prednisone therapy. Br Med J 1992; 31: 91-96.

20. Hall GM, Spector TD et al. The effect of Rheumatoid Arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993; 36(1): 1510-1516.

21. Sambrook PN. Osteoporosis in Rheumatoid Arthritis: what is the role of antirheumatic therapy? Lancet 1994; 344: 3-4.

22. Laan RFJM, Van Riel PLCM et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993; 119: 963-968.

23. Van Schaardenburg D, Valkera R et al. Prednisone treatment of elderly-onset Rheumatoid Arthritis. Arthritis Rheum 1995; 38: 334-342.

24. Laan RFJM, Buijs WCAM et al. Bone mineral density in patients with recente onset Rheumatoid Arthritis: influence of disease activity and function capacity. Ann Rheum Dis 1993; 52: 21-26.

25. Gough A, Lilley J et al. Rapid bone loss in early Rheumatoid Arthritis (RA) due to disease activity (abstract). Presented at: Fourth International Symposium on Osteoporosis. Hong Kong p.23.

26. Gough AKS, Lilley J et al. Generalized bone loss in patients with early Rheumatoid Arthritis. Lancet 1994; 344: 23-27.

27. Spector TD, Hall GM et al. Risk of vertebral fracture in women with Rheumatoid Arthritis. Br Me J 1993; 306: 558.

28. Sambrook PN, Eisman JA, Yeates Mg et al. Osteoporosis in Rheumatoid Arthritis, safety of low dose corticosteroids. Ann Rheum Dis 1986; 45: 950-953.

29. D'Angelo A, Fabris A et al. Mineral Metabolis and bone mineral content in Rheumatoid Arthritis. Effect of corticosteroids. Clin Exp Rheumatc 1985; 3: 1143-146.

30. Leboff MS, Wade JP et al. Low dose prednison does not affect calcium homeostasis or bone density in postmenopausal women with Rheumatol Arthritis. J Rheumatol 1991; 18: 339-344.

31. Garton MJ, Reid DM. Bone mineral density of the anteroposterior and lateral dimensions of the spin in men with Rheumatoid Arthritis: Effects of low dose corticosteroids. Arthritis Rheum 1993; 36: 222-228.

32. Buckley LM, Leib ES et al. Effects of low Dose Corticosteroids on the Bone Mineral Density of Patients with Rheumatoid Arthritis. J Rheumatol 1995; 22: 1055-1059.

33. Formiga F, Moga I, Nolla JM, et al. Loss of bon mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Di 1995; 54: 274-276.

34. Jergas M, Genant HK. Current methods and recent advances in the diagnosis of Osteoporosis. Arthritis Rheum 1993; 36: 1649-1662.

35. World Health Organization. Assessment of fractures risk and its application to screening for postmenopausal osteoporosis. WHO Technical Repor 1994; Series 843.

36. Reid IR, Evans MC, Stapleton. Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induce bone loss. J Bone Miner Res 1992; 7: 1221-1225.

37. Villareal DT, Civitelli R, Gennari C, Avioli LV. Is there an Effective Treatment for Glucocorticoid-Induced Osteoporisis? Calcif Tissue Int 1991; 49: 141-142.

38. Silverman SL. Management of Corticosteroid-induce Osteoporosis: A Clinician's Perspective. Calcif Tissue Int 1992; 50: 101-103.

39. Libanati CR, Baylink DJ. Prevention and Treatment of Glucocorticoid-Induce Osteoporisis. A path genetic Perspective. Chest 1992; 102: 1426-143.

40. Eastell R. Management of corticosteroid-induce osteoporosis. J Int Med 1995; 237: 439-447.

41. Spector TD, Sambrook PN. Steroid osteoporosis. A pragmatic approach is needed while prospective trials are awaited. BMJ 1993; 307: 519-520.

42. Peat ID, Healy SE, Reid DM, Ralston SH. Stero induced osteoporosis: an oportunity for prevention? Ann Rheum Dis 1995; 54: 66-68.

43. Lukert BP, Johnson BE, Robinson RG. Estrogen a Progesterone Therapy Reduces Glucocorticoid-1 duced Bone Loss. J Bone Min Res 1992; 7: 1063-1069.

44. Boumpas DDT, Fessler BJ, Austin HA et al. Systemic Lupus Erythematouss: Emerging Concept Ann Intern Med 1995; 123: 42-53.

45. Adachi JD, Steele M, Gordon M et al. Nasal salmo Calcitonin in the prevention of corticosteroid-induce osteoporosis. Arthritis Rheum 1992; 35: s120.

46. Sambrook PN, Birmingham J, Kelly PJ, Kempler S, Pocock Na, Eisman JA. Prevention of corticosteroid osteoporosis: a comparison of calcium calcitriol and Calcitonin. N Engl J Med 1993; 328: 1747-52.

47. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid bone loss. Osteoporosis Int 1993; 3 (Suppl 1): S141-143.

48. Mulder H, Struys A. Intermittent cyclical Etridronate in the prevention of corticosteroid-induced bone loss. Br. J Rheumatol 1994; 33: 348-350.

49. Van Kesteren RG, Duursma SA, Visser WJ, Van de Sluys V, Backer Dirks O. Fluoride in serum an bone during treatment of osteoporosis with sodiu fluoride, calcium and vitamin D. Metab Bone Di Rel Res 1982; 4: 31-37.

50. Rizzoli R, Chevalley T. Slosman DO, Bonjour J. Sodium Monofluorophosphate Increases Vertebral Bone Mineral Density in Patients with Corticosteroid-Induced Osteoporosis. Osteoporosis In 1995; 5: 39-46.

51. Adami S, Fossaluzza V, Rossini M et al. The prevention of cortocosteroid-induced osteoporosis with nandrolone decanoate. Bone Mine
1991; 15: 72-81.

52. Seino Y, Ishizuka SE, Shima M, Tanaka H. Vitamin D in bone formation. Osteoporosis Int 3 (Suppl 1): S196-198.

Regresar al Artículo